These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 23822591

  • 21. Quantitative analysis of the effect of supersaturation on in vivo drug absorption.
    Takano R, Takata N, Saito R, Furumoto K, Higo S, Hayashi Y, Machida M, Aso Y, Yamashita S.
    Mol Pharm; 2010 Oct 04; 7(5):1431-40. PubMed ID: 20704264
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media.
    Sunesen VH, Pedersen BL, Kristensen HG, Müllertz A.
    Eur J Pharm Sci; 2005 Mar 04; 24(4):305-13. PubMed ID: 15734297
    [Abstract] [Full Text] [Related]

  • 25. Mechanisms by which moisture generates cocrystals.
    Jayasankar A, Good DJ, Rodríguez-Hornedo N.
    Mol Pharm; 2007 Mar 04; 4(3):360-72. PubMed ID: 17488034
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of a nanoemulsion formulation strategy for oral bioavailability enhancement of danazol in rats and dogs.
    Devalapally H, Silchenko S, Zhou F, McDade J, Goloverda G, Owen A, Hidalgo IJ.
    J Pharm Sci; 2013 Oct 04; 102(10):3808-15. PubMed ID: 23878097
    [Abstract] [Full Text] [Related]

  • 27. Polymorphism in sulfadimidine/4-aminosalicylic acid cocrystals: solid-state characterization and physicochemical properties.
    Grossjohann C, Serrano DR, Paluch KJ, O'Connell P, Vella-Zarb L, Manesiotis P, Mccabe T, Tajber L, Corrigan OI, Healy AM.
    J Pharm Sci; 2015 Apr 04; 104(4):1385-98. PubMed ID: 25605031
    [Abstract] [Full Text] [Related]

  • 28. The role of pH and dose/solubility ratio on cocrystal dissolution, drug supersaturation and precipitation.
    Machado TC, Kuminek G, Cardoso SG, Rodríguez-Hornedo N.
    Eur J Pharm Sci; 2020 Sep 01; 152():105422. PubMed ID: 32531350
    [Abstract] [Full Text] [Related]

  • 29. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
    Tomaszewska I, Karki S, Shur J, Price R, Fotaki N.
    Int J Pharm; 2013 Sep 10; 453(2):380-8. PubMed ID: 23727143
    [Abstract] [Full Text] [Related]

  • 30. Cocrystal of Apixaban-Quercetin: Improving Solubility and Bioavailability of Drug Combination of Two Poorly Soluble Drugs.
    Zhang L, Kong D, Wang H, Jiao L, Zhao X, Song J, Yang D, Yang H, Yang S, Du G, Lu Y.
    Molecules; 2021 May 03; 26(9):. PubMed ID: 34063645
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Cocrystal formulations: A case study of topical formulations consisting of ferulic acid cocrystals.
    Aitipamula S, Das S.
    Eur J Pharm Biopharm; 2020 Apr 03; 149():95-104. PubMed ID: 32035236
    [Abstract] [Full Text] [Related]

  • 35. A strategy to improve the oral availability of baicalein: The baicalein-theophylline cocrystal.
    Li W, Pi J, Zhang Y, Ma X, Zhang B, Wang S, Qi D, Li N, Guo P, Liu Z.
    Fitoterapia; 2018 Sep 03; 129():85-93. PubMed ID: 29936192
    [Abstract] [Full Text] [Related]

  • 36. Bioavailability of indomethacin-saccharin cocrystals.
    Jung MS, Kim JS, Kim MS, Alhalaweh A, Cho W, Hwang SJ, Velaga SP.
    J Pharm Pharmacol; 2010 Nov 03; 62(11):1560-8. PubMed ID: 21039541
    [Abstract] [Full Text] [Related]

  • 37. Pharmaceutical Cocrystal: A Novel Approach to Tailor the Biopharmaceutical Properties of a Poorly Water Soluble Drug.
    Srivastava D, Fatima Z, Kaur CD, Tulsankar SL, Nashik SS, Rizvi DA.
    Recent Pat Drug Deliv Formul; 2019 Nov 03; 13(1):62-69. PubMed ID: 30848223
    [Abstract] [Full Text] [Related]

  • 38. Novel Aceclofenac-l-Cystine and Aceclofenac-Urea Cocrystals with Enhanced Oral Bioavailability.
    Kumar S, Gupta A, Mishra CK, Singh S.
    Curr Drug Deliv; 2021 Nov 03; 18(8):1174-1181. PubMed ID: 33602085
    [Abstract] [Full Text] [Related]

  • 39. Pharmaceutical cocrystals and poorly soluble drugs.
    Thakuria R, Delori A, Jones W, Lipert MP, Roy L, Rodríguez-Hornedo N.
    Int J Pharm; 2013 Aug 30; 453(1):101-25. PubMed ID: 23207015
    [Abstract] [Full Text] [Related]

  • 40. Danazol oral absorption modelling in the fasted dog: An example of mechanistic understanding of formulation effects on drug pharmacokinetics.
    Pade D, Jamei M, Turner DB, Mistry B, Martinez MN.
    Eur J Pharm Biopharm; 2019 Aug 30; 141():191-209. PubMed ID: 31150808
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.